We integrate targeted recruitment with the science of biomarkers to streamline pre-screening. Our customizable early screening tool, includes remote biological sampling and delivers only trial-ready patients, more likely to be randomized, to sites, accelerating enrollment in the process.

Identifying eligible patients earlier reduces costs associated with screen failures, accelerating enrollment timelines, and optimizing site performance, so study teams are able to dedicate more time to trial-ready patients and reduce time and effort spent scheduling costly procedures such as CSF tests & PET scans.

By testing for specific biomarkers at pre-screening, patients avoid a potentially long and drawn-out enrollment process and reduce the need for painful and invasive procedures like CSF tests & PET scans.